BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27774627)

  • 1. A case-cohort approach for multi-state models in hospital epidemiology.
    von Cube M; Schumacher M; Palomar-Martinez M; Olaechea-Astigarraga P; Alvarez-Lerma F; Wolkewitz M
    Stat Med; 2017 Feb; 36(3):481-495. PubMed ID: 27774627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A full competing risk analysis of hospital-acquired infections can easily be performed by a case-cohort approach.
    Wolkewitz M; Palomar-Martinez M; Olaechea-Astigarraga P; Alvarez-Lerma F; Schumacher M
    J Clin Epidemiol; 2016 Jun; 74():187-93. PubMed ID: 26633600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent covariates in the proportional subdistribution hazards model for competing risks.
    Beyersmann J; Schumacher M
    Biostatistics; 2008 Oct; 9(4):765-76. PubMed ID: 18434297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving nested case-control studies to conduct a full competing-risks analysis for nosocomial infections.
    Hazard D; Schumacher M; Palomar-Martinez M; Alvarez-Lerma F; Olaechea-Astigarraga P; Wolkewitz M
    Infect Control Hosp Epidemiol; 2018 Oct; 39(10):1196-1201. PubMed ID: 30157989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic parametric analysis for a multi-state model in hospital epidemiology.
    von Cube M; Schumacher M; Wolkewitz M
    BMC Med Res Methodol; 2017 Jul; 17(1):111. PubMed ID: 28728582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The competing risks illness-death model under cross-sectional sampling.
    Mandel M
    Biostatistics; 2010 Apr; 11(2):290-303. PubMed ID: 19933879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nested case-control studies in cohorts with competing events.
    Wolkewitz M; Cooper BS; Palomar-Martinez M; Olaechea-Astigarraga P; Alvarez-Lerma F; Schumacher M
    Epidemiology; 2014 Jan; 25(1):122-5. PubMed ID: 24240653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Landmark prediction of nosocomial infection risk to disentangle short- and long-stay patients.
    Wolkewitz M; Zortel M; Palomar-Martinez M; Alvarez-Lerma F; Olaechea-Astigarraga P; Schumacher M
    J Hosp Infect; 2017 May; 96(1):81-84. PubMed ID: 28285741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling two cause-specific hazards of competing risks in one cumulative proportional odds model?
    Ohneberg K; Schumacher M; Beyersmann J
    Stat Med; 2017 Nov; 36(27):4353-4363. PubMed ID: 28833435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bias due to censoring of deaths when calculating extra length of stay for patients acquiring a hospital infection.
    Rahman S; von Cube M; Schumacher M; Wolkewitz M
    BMC Med Res Methodol; 2018 May; 18(1):49. PubMed ID: 29843610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital-acquired infections--appropriate statistical treatment is urgently needed!
    Schumacher M; Allignol A; Beyersmann J; Binder N; Wolkewitz M
    Int J Epidemiol; 2013 Oct; 42(5):1502-8. PubMed ID: 24038717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation shows undesirable results for competing risks analysis with time-dependent covariates for clinical outcomes.
    Poguntke I; Schumacher M; Beyersmann J; Wolkewitz M
    BMC Med Res Methodol; 2018 Jul; 18(1):79. PubMed ID: 30012114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity and mortality associated with primary and catheter-related bloodstream infections in critically ill patients.
    Olaechea PM; Palomar M; Álvarez-Lerma F; Otal JJ; Insausti J; López-Pueyo MJ;
    Rev Esp Quimioter; 2013 Mar; 26(1):21-9. PubMed ID: 23546458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A competing risks approach for nonparametric estimation of transition probabilities in a non-Markov illness-death model.
    Allignol A; Beyersmann J; Gerds T; Latouche A
    Lifetime Data Anal; 2014 Oct; 20(4):495-513. PubMed ID: 23807694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Being Overweight Is Associated With Greater Survival in ICU Patients: Results From the Intensive Care Over Nations Audit.
    Sakr Y; Alhussami I; Nanchal R; Wunderink RG; Pellis T; Wittebole X; Martin-Loeches I; François B; Leone M; Vincent JL;
    Crit Care Med; 2015 Dec; 43(12):2623-32. PubMed ID: 26427591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling in-hospital patient survival during the first 28 days after intensive care unit admission: a prognostic model for clinical trials in general critically ill patients.
    Moreno RP; Metnitz PG; Metnitz B; Bauer P; Afonso de Carvalho S; Hoechtl A;
    J Crit Care; 2008 Sep; 23(3):339-48. PubMed ID: 18725038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-cohort designs and analysis for clustered failure time data.
    Lu SE; Shih JH
    Biometrics; 2006 Dec; 62(4):1138-48. PubMed ID: 17156289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Length of stay and mortality due to Clostridium difficile infection acquired in the intensive care unit.
    Dodek PM; Norena M; Ayas NT; Romney M; Wong H
    J Crit Care; 2013 Aug; 28(4):335-40. PubMed ID: 23337482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study.
    Iwashyna TJ; Hodgson CL; Pilcher D; Bailey M; van Lint A; Chavan S; Bellomo R
    Lancet Respir Med; 2016 Jul; 4(7):566-573. PubMed ID: 27155770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study.
    Dautzenberg MJ; Wekesa AN; Gniadkowski M; Antoniadou A; Giamarellou H; Petrikkos GL; Skiada A; Brun-Buisson C; Bonten MJ; Derde LP;
    Crit Care Med; 2015 Jun; 43(6):1170-7. PubMed ID: 25882764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.